Hoth Therapeutics OverviewHoth Therapeutics Other Income Expense Net
Other Income/Expense Net for HOTH.
Quarterly Other Income/Expense
-$44016.00
↓ 24418.23% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
-$152150.00
↓ 1207.43% YoY
Trailing 12 months ending Mar 31, 2026